Commission Implementing Regulation (EU) 2020/1643

of 5 November 2020

amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances calcium phosphide, denathonium benzoate, haloxyfop-P, imidacloprid, pencycuron and zeta-cypermethrin

(Text with EEA relevance) (revoked)